Nephrocare Health Services Ltd.
617.15-3.8 (-0.61%)
14 Oct, 12:00 AM
Stock News
Nephrocare Health Services Ltd. latest news covering earnings updates, regulatory announcements, analyst actions and market-moving events.
Moneycontrol
Axis Direct bullish on Dr Lal PathLabs, Vijaya Diagnostic and Nephrocare, assigns 'Buy' ratings with up to 21% upside
Axis Direct assigned a Buy rating to Nephrocare Health Services, also known as NephroPlus, with a target price of Rs 750 versus a current price of Rs 616, implying 21% upside, noting its 490 dialysis clinics across 269 cities, FY25 revenue of Rs 756 crore after 31.5% CAGR and 22.1% EBITDA margin.
12th Oct '26 7:33 am
Read full article on moneycontrol.com